Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05426083 · ClinicalTrials.gov registry record
Left Ventricular Physiological Effects of Veno-Arterial Extracorporeal Membrane Oxygenation Support During Cardiogenic Shock
A clinical trial of Acute Coronary Syndrome and Cardiogenic Shock, sponsored by University of Minnesota.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT05426083 is a study of Acute Coronary Syndrome and Cardiogenic Shock that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 200 participants, below the 2,717-participant average among 40 other Acute Coronary Syndrome trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05426083, a study of Acute Coronary Syndrome and Cardiogenic Shock, is actively recruiting participants, sponsored by University of Minnesota.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
A Clinical Events Committee (CEC) will include Cardiac Surgery Professor and chief of cardiac surgery Rose Kelly MD, Professor of Medicine Ganesh Raveendran MD at the University of Minnesota who is the direction of Interventional Cardiology and Professor of Medicine at the University of Minnesota David Benditt. They will review and adjudicate serious and unexpected adverse events independently from the PI and co investigators.
Conditions Studied
Interventions
- OTHER Physiological Assessment
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2022-08-04 |
| Est. Completion | 2026-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05426083
The ClinicalTrials.gov registry entry for NCT05426083 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,717-participant average among 40 other Acute Coronary Syndrome trials with a reported enrollment target (93% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Acute Coronary Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Physiological Assessment is the first listed.
NCT05426083 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT05426083 about?
NCT05426083 is a clinical study titled "Left Ventricular Physiological Effects of Veno-Arterial Extracorporeal Membrane Oxygenation Support During Cardiogenic Shock". A Clinical Events Committee (CEC) will include Cardiac Surgery Professor and chief of cardiac surgery Rose Kelly MD, Professor of Medicine Ganesh Raveendran MD at the University of Minnesota who is the direction of Interventional Cardiology and Professor of Medicine at the University of Minnesota Da...
What is the current status of trial NCT05426083?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2022-08-04. Estimated completion is 2026-12-31.
What conditions does trial NCT05426083 study?
This clinical trial studies the following conditions: Acute Coronary Syndrome, Cardiogenic Shock.
What interventions are being tested in trial NCT05426083?
The interventions under investigation include: Physiological Assessment (OTHER).
Who is sponsoring clinical trial NCT05426083?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05426083 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Coronary Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Polypill for Acute Coronary Syndrome
RECRUITING · Phase 2
-
Positive Emotions Following Acute Cardiac Events
RECRUITING · NA
-
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
RECRUITING · Phase 3
-
A Prospective Research Investigation of Ischemia Using MCG
RECRUITING
-
AngelMed Guardian® System PMA Post Approval Study
RECRUITING
-
Online Tai Chi Plus Fitbit After ACS
ACTIVE NOT RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.